MDX-1100

BIOLOGICAL2 trials

Sponsors

Bristol-Myers Squibb

Conditions

Rheumatoid ArthritisUlcerative Colitis

Phase 2

A Study of MDX-1100 in Subjects With Active Ulcerative Colitis

CompletedNCT00656890

Bristol-Myers SquibbUlcerative Colitis

Start: 2008-04-30End: 2009-09-30Updated: 2015-10-12

Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (RA)

CompletedNCT01017367

Bristol-Myers SquibbRheumatoid Arthritis

Start: 2008-02-29End: 2009-05-31Updated: 2010-04-23

Related Papers

Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study.

2013-03-05119 citations